http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013542999-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06
filingDate 2011-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2013-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2013542999-A
titleOfInvention CBP / catenin antagonist for promoting asymmetric division of somatic stem cells
abstract Methods of treating aging or conditions associated with aging, symptoms or diseases; methods of promoting hair growth, regrowth or pigmentation (or prevention of hair loss); methods of increasing adenosine receptor expression in dermal cells (hair Skin condition or disease or at least one symptom thereof (eg, wrinkles, hyperpigmentation, redness, rosacea, dryness, cracks, loss of tension, loss of elasticity, including cosmetic treatment); A method of treating thinning and loss of vitality). The method includes administering a sufficient amount of a disclosed CBP / catenin (eg, CBP / β-catenin) antagonist, particularly where administration is compared to symmetrical division in an appropriate somatic stem cell population. In an amount and manner sufficient to increase the number of asymmetric replication divisions, or at the expense of symmetric division in an appropriate somatic stem cell population. [Selection] Figure 15
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7178143-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019503335-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017088633-A
priorityDate 2010-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6762185-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010504081-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009517085-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008533155-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010124365-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7563825-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393686
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60961

Total number of triples: 54.